期刊文献+

深圳市成年女性生殖道高危型人乳头瘤病毒感染与宫颈癌患病调查 被引量:26

Investigation on the prevalence of high risk human papillomavirus and cervical cancer among adult women, in Shenzhen
原文传递
导出
摘要 目的了解深圳市成年女性生殖道高危型人乳头瘤病毒(HPV)感染与宫颈癌患病情况。方法2006年4月至2010年4月采取整群抽样方法,对深圳市罗湖、福田、南山、龙岗和保安区20-59岁有性生活史的女性开展宫颈癌筛查。受筛查妇女均行宫颈脱落细胞液基细胞学检查(LCT)或者新柏氏液基细胞学检查(TCT)和第二代杂交捕获技术(HC-Ⅱ)。对HPV阳性,且细胞学≥未明确诊断意义的不典型鳞状上皮细胞(ASC-US)和/或LCT/TCT≥低度鳞状上皮内瘤样病变(LSIL)的妇女均行阴道镜下活组织病理检查,以确定有无宫颈上皮内瘤样病变(CIN)或宫颈癌。结果共筛查10210名妇女,其中10017人检验结果完整,高危型HPV-DNA的总检出率为16.29%,其中20~、30~、35~、40~、45~和50~59岁组的检出率分别为17.37%、15.59%、16.33%、14.74%、17.16%和17.98%。年龄别HPV感染率曲线呈“w”形。25~和50~59岁组HPV感染率明显高于其他各年龄组(χ^2=4.50,P=0.03);CINI、CINⅡ/Ⅲ、宫颈癌的现患率分别为5.32%、2.21%和0.12%,CINⅠ明显高于CINⅡ/Ⅲ(χ^2=134.15,P〈0.001),45~岁组宫颈癌现患率最高,为0.12%。深圳市各区HPV感染差异有统计学意义(χ^2=17.81,P=0.03),其中福田区和罗湖区HPV感染率高于南山、宝安和龙岗区;宝安区CIN现患率最低,其他各区CIN现患率问的差异无统计学意义(χ^2=4.84,P=0.18)。结论深圳市成年女性宫颈癌患病率较低,宫颈病变多处于发病早期,重点应预防HPV感染和治疗CIN。 Objective To investigate the prevalence of high risk human papillomavirus (HPV) genital infection and cervical cancer in adult women from Shenzhen. Methods Cluster sampling was used to investigate the prevalence of HPV infection and cervical cancer from women aged 20-59 years old living in Luohu, Futian, Nanshan, Longgang and Baoan districts in Shenzhen from April 2006 to April 2010. All women were detected for liquid-based cytology test (LCT) or Thinprep cytologic test (TCT) and high-risk HPV-DNA test with hybrid capture Ⅱ (HC-Ⅱ ). All women with ≥ASC-US by cytology and/or a positive HC- Ⅱ test were asked to return for colposcopy and four-quadrant biopsy. Endocervical curettage was performed. Pathological finding were used as the gold standard of the diagnosis of cervical intraepithelial neoplasia. Results 10 210 women were involved in the study and 10 017 of them having completed data. The overall positive rate of high-risk HPV-DNA was 16.29%. HPV positive rates in 20-, 30-, 35-, 40-, 45-, 50-59 age groups were 17.37%, 15.59% , 16.33%, 14.74%, 17.16% and 17.98%, respectively. The curve of HPV infection rates in different age groups appeared a 'W' shape. HPV infection rates in the 25- years-olds and 50-59 year-olds groups were significantly higher than the other age groups (χ^2=4.50, P=0.03). The overall prevalence rate of cervical intraepithelial lesions (CIN) was 7.52%, of which the prevalence rates of low-grade cervical intraepithelial lesions (CIN Ⅰ) was 5.32% high-grade cervical intraepithelial lesions (CIN Ⅱ/Ⅲ ) was 2.21%, cervical cancer was 0.12%. The prevalence of CIN I was significantly higher than the CIN Ⅱ/Ⅲ (χ^2=134.15 ,P〈0.001 ). The prevalence of cervical cancer in 45- age group was 0.12%, the highest. HPV infection rates increased with the grades of cervical lesions including women without CIN as 44.31%, in CIN Ⅰ as 70.73%, in CIN Ⅱ as 86.73%, and in CIN Ⅲ as 96.75% and in cancer as 100.00%. The HPV infection rates were different in districts (χ^2= 17.81, P= 0.03), with Futian and Luohu higher than those of Nanshan, Longgang and Baoan district. The prevalence rate of CIN in Baoan was lower than other districts. The CIN prevalence rates were not significantly different among the other districts of Shenzhen (χ^2=4.84, P= 0.18). Conclusion The prevalence of cervical cancer was low in adult women living in Shenzhen, with cervical lesions still in the early stage. Prevention of HPV infection and treatment of CIN were the key points for the prevention of cervical cancer.
出处 《中华流行病学杂志》 CAS CSCD 北大核心 2012年第8期799-802,共4页 Chinese Journal of Epidemiology
关键词 宫颈肿瘤 人乳头瘤病毒 宫颈上皮内瘤样病变 Cervical neoplasms Human papillomavirus Cervical intraepithelial lesion
  • 相关文献

参考文献10

  • 1Wu RF, Dai M, Qiao YL, et al. Human papillomavirus infection in women in Shenzhen city, People' s Republic of China, a population typical of recent Chinese urbanization. Int J Cancer,2007,121(6) : 1306-1311.
  • 2吴瑞芳,刘植华,周庆芝,乌兰娜,王倩,李晴,李霓,刘志红,石菊芳,李瑞珍,张长淮,周艳秋,刘彬,翁雷明,乔友林.深圳女性生殖道人乳头瘤病毒感染与子宫颈上皮内瘤样病变现患率调查及子宫颈癌筛查方法的评价[J].中国医学科学院学报,2010,32(1):90-95. 被引量:57
  • 3刘彬,陈汶,任生达,刘新伏,马俊飞,崔剑峰,王秀荣,陈凤,乔友林.液基细胞学剩余标本筛查子宫颈病变中人乳头状瘤病毒DNA的应用[J].中华检验医学杂志,2005,28(5):495-497. 被引量:18
  • 4Qiao YL, Franeesehi S, Belinson JL, et al. HPV prevalence in Chinese women: a population based multiple center survey in China's Mainland. Oral presentation 1B-01, 24th International PapiUomavirus Conference and Clinical Workshop, 03-09-2007 Beijing International Convention Center. China.
  • 5Castle PE, Schiffman M, Herrero R, et al. A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica. J Infect Dis, 2005, 191 (11):1808-1816.
  • 6Sankaranarayanan R, Nene BM, Shastri SS, et al. HPV screening for cervical cancer in rural India. N Engl J Med, 2009,360 (14) : 1385-1394.
  • 7Moscicki AB. Impact of HPV infection in adolescent populations. J Adolesc Health, 2005,37 (6 Supp 1) : S3 -9.
  • 8Bory JP, Cucherousset J, Lorenzato M, et al. Recurrent human papillomavirus infection detected with the hybrid capture II assay selects women with normal cervical smears at risk for developing high grade cervical lesions: a longitudinal study of 3091 women. Int J Cancer, 2002,102 ( 5 ) : 519-525.
  • 9Bhatla N, Moda N. The clinical utility of HPV DNA testing in cervical cancer screening strategies, Indian J Med Res, 2009,130 (3) :261-265.
  • 10Wahlstrom C, Iftner T, Dillner J,et al. Population-based study of screening test performance indices of three human papillomavirus DNA tests. J Med Virol, 2007,79 (8) : 1169-1175.

二级参考文献12

  • 1李从铸,翟玉霞.宫颈癌年轻化及其治疗模式的临床研究[J].癌变.畸变.突变,2005,17(1):36-38. 被引量:21
  • 2刘彬,陈汶,任生达,刘新伏,马俊飞,崔剑峰,王秀荣,陈凤,乔友林.液基细胞学剩余标本筛查子宫颈病变中人乳头状瘤病毒DNA的应用[J].中华检验医学杂志,2005,28(5):495-497. 被引量:18
  • 3ter Harmsel B, Smedts F, Kuijpers J ,et al. Relationship between human papillomavirus type 16 in the cervix and intraepithelial neoplasia. Obstet Gynecol , 1999, 93: 46-50.
  • 4Koss LG. The papnicolaou test for cervical detection. A triumph and a tragedy. JAMA, 1989, 261: 737-743.
  • 5Strickler H, Shah K. Re: Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst, 2001, 93: 951.
  • 6Belinson JL, Qiao YL, Pretorius RG, et al. Shanxi Province cervical cancer screening study Ⅱ: self-sampling for high-risk human papillomavirus compared to direct sampling for human papillomavirus and liquid based cervical cytology. Int J Gynecol Cancer, 2003,13: 819-826.
  • 7Nobbenhuis MAE, Walboomers JM, Helmerhorst TJ,et al. Relation of human papillomavirus status to cervical lesions and consequences for cervical cancer screening: a prospective study. Lancet, 1999, 354: 20-25.
  • 8Zuna RE, Moore W, Dunn ST. HPV DNA testing of the residual sample of liquid-based Pap test: utility as a quality assurance monitor. Mod Pathol, 2001, 14: 147-151.
  • 9戎寿德,陈汶,吴令英,张洵,沈贵华,刘韵源,赵方辉,马俊飞,乔友林.山西省襄垣县宫颈癌危险因素分析[J].中华预防医学杂志,2002,36(1):41-43. 被引量:55
  • 10乔友林,章文华,李凌,潘秦镜,杨玲,吴令英,戍寿德,李爱玲,张询,任生达,Belinson J.子宫颈癌筛查方法的横断面比较研究[J].中国医学科学院学报,2002,24(1):50-53. 被引量:351

共引文献72

同被引文献210

引证文献26

二级引证文献203

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部